Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Biomed Research International|May 14, 2021
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing AutophagyWeiya Cao, Xueke Liu, Yinci Zhang, et al.Nanoscale Research Letters|October 23, 2015
PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral SpreadXiaolong Tang, Yong Liang, Xinkuang Liu, et al.Journal of Translational Medicine|November 8, 2023
Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathwayJuan Wei, Chunyan Chen, Jing Feng, et al.Nanoscale Research Letters|November 26, 2020
hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling PathwayJing Shen, Wenpeng Cai, Yongfang Ma, et al.The Journal of Biological Chemistry|May 7, 2023
The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytesHaixia Ma, Valentina Sukonina, Wei Zhang, et al.Journal of Cancer Research and Clinical Oncology|April 29, 2020
Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cellsAmin Li, Weiya Cao, Xueke Liu, et al.Frontiers in Cell and Developmental Biology|August 6, 2020
MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor MicroenvironmentNannan Song, Peng Li, Pingping Song, et al.Frontiers in Cell and Developmental Biology|September 25, 2020
Corrigendum: MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor MicroenvironmentNannan Song, Peng Li, Pingping Song, et al.Molecular Biotechnology|March 25, 2024
Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5pLuoluo Wang, Shuping Zhou, Yi Ruan, et al.American Journal of Translational Research|January 15, 2020
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathwayXueke Liu, Chunmei Xie, Amin Li, et al.Pageof 8